Browse our comprehensive archive of press releases by date.
Select a specific day to access all press releases published on European Global Times.
Press releases published on April 29, 2025
Olon Group Memperkukuh Kepimpinannya dalam Bioproduksi dengan Dua Pelantikan Strategik di Perancis
GlobeNewswire
·
April 29, 2025
MILAN, April 29, 2025 (GLOBE NEWSWIRE) -- Olon Group, sebuah CDMO farmaseutikal global terkemuka, mengumumkan pelantikan Jérôme Bédier sebagai Ketua Pegawai Eksekutif bagi entiti di Perancis dan Andrea Conforto sebagai Naib Presiden M…
Olon Group 在法国完成两项战略性任命，进一步巩固其在生物生产领域的领先地位
GlobeNewswire
·
April 29, 2025
米兰, April 29, 2025 (GLOBE NEWSWIRE) -- 全球领先的制药合同研发生产组织 (CDMO) Olon Group 宣布任命 Jérôme Bédier 为其法国子公司的首席执行官，同时任命 Andrea Conforto 担任旗下专注于生物制剂 CDMO 服务的业务部门——Olon Biotech CDMO 事业部的市场和销售副总裁。 上述任命进一步巩固了 Olon 在抗体药物偶联物 (ADC)、高活性原料药 (HPAPI) 及微生物生物生产领域拓展能力的战略布局。 ADC、 …
Olon Group 在法國的兩項戰略任命加強了其在生物製藥領域的領導地位
GlobeNewswire
·
April 29, 2025
米蘭, April 29, 2025 (GLOBE NEWSWIRE) -- 全球領先的藥物合同訂製研發和生產組織 (CDMO) 公司 Olon Group 宣布任命 Jérôme Bédier 為其法國實體的行政總裁，並任命 Andrea Conforto 為 Olon 生物技術部門的 CDMO 市場及銷售副總裁 (M…
Milliways, the chewing gum revolution, arrives in France
GlobeNewswire
·
April 29, 2025
Milliways, the fast-growing British plastic-free chewing gum brand, announces its launch in France with the ambition of transforming a market that has remained unchanged for decades. Already the leader of the “plastic-free” category in the UK, Milliways …
Milliways, la révolution du chewing-gum, débarque en France
GlobeNewswire
·
April 29, 2025
Milliways, la marque britannique de chewing-gum sans plastique en pleine expansion, annonce son lancement en France avec l’ambition de transformer un marché resté figé depuis des décennies. Déjà leader de la catégorie “plastic-free” au Royaume-Uni, …
Atsena Therapeutics to Present at May Scientific Conferences
GlobeNewswire
·
April 29, 2025
DURHAM, N.C., April 29, 2025 (GLOBE NEWSWIRE) -- Atsena Therapeutics, a clinical-stage gene therapy company focused on using the life-changing power of genetic medicine to reverse or prevent blindness, today announced it will present at the following …
DATE CORRECTION – Amerigo will report Q1-2025 Financial Results on May 7, 2025
GlobeNewswire
·
April 29, 2025
VANCOUVER, British Columbia, April 29, 2025 (GLOBE NEWSWIRE) -- Amerigo Resources Ltd. (TSX: ARG; OTCQX: ARREF) (“Amerigo” or the “Company”) is issuing the following date correction, which was included in its Operational Results news release issued on …
Co-Diagnostics, Inc. Announces First Quarter 2025 Earnings Release Date and Webcast
GlobeNewswire
·
April 29, 2025
SALT LAKE CITY, April 29, 2025 (GLOBE NEWSWIRE) -- Co-Diagnostics, Inc. (NASDAQ: CODX), a molecular diagnostics company with a unique, patented platform for the development of molecular diagnostic tests, announced today it will release its first quarter …
ECARX and Qualcomm Strengthen Relationship to Expand ECARX Product Portfolio Based on Snapdragon Cockpit Platforms
GlobeNewswire
·
April 29, 2025
SHANGHAI, April 29, 2025 (GLOBE NEWSWIRE) -- ECARX (Nasdaq: ECX), (“ECARX” or the “Company”), a global automotive technology provider, announced a new phase of its collaboration with Qualcomm Technologies, Inc. Building on their long-term relationship, the …
Oxford-Harrington Rare Disease Centre Appoints Majid Jafar to its Advisory Council
GlobeNewswire
·
April 29, 2025
Mr. Jafar is a distinguished international business leader and co-founder of the Loulou Foundation OXFORD, UK and CLEVELAND, Ohio, US, 29 April 2025 – The Oxford-Harrington Rare Disease Centre (‘OHC’), a partnership between the University of Oxford, UK and …
EDAP Announces Positive Results from the FARP Randomized Controlled Trial Presented at the American Urological Association (AUA) Annual Meeting
GlobeNewswire
·
April 29, 2025
Final 3-year outcome of Focal Ablation versus Radical Prostatectomy (FARP) Randomized Controlled Trial (RCT) presented at 120th AUA Annual Meeting on Sunday, April 27, 2025. Study achieved its primary endpoint and demonstrated that the rate of treatment …
Press Release: When every second counts: Sanofi, McLaren Racing and United Autosports join forces to raise meningitis awareness at Le Mans 24 Hours race
GlobeNewswire
·
April 29, 2025
When every second counts: Sanofi, McLaren Racing and United Autosports join forces to raise meningitis awareness at Le Mans 24 Hours race Paris, April 29, 2025. Sanofi is proud to unveil an exciting new chapter in its mission to fight meningitis, as it …
Communiqué de presse :
GlobeNewswire
·
April 29, 2025
Quand chaque seconde compte : Sanofi, McLaren Racing et United Autosports s'unissent pour sensibiliser à la méningite aux 24 Heures du Mans Paris, le 29 avril 2025. Sanofi est fière de présenter une nouvelle étape significative dans sa mission de lutte …
Ocular Therapeutix™ to Participate in Upcoming Investor and Scientific Conferences
GlobeNewswire
·
April 29, 2025
BEDFORD, Mass., April 29, 2025 (GLOBE NEWSWIRE) -- Ocular Therapeutix, Inc. (NASDAQ: OCUL, “Ocular”), a biopharmaceutical company committed to redefining the retina experience, today announced participation in several upcoming investor and scientific …
EsoBiotec to Present Preclinical Proof-of-Concept Data for Its Off-the-Shelf ENaBL In Vivo Cell Therapy Platform at the 28th Annual Meeting of the American Society of Gene and Cell Therapy
GlobeNewswire
·
April 29, 2025
Poster talk will present safety and efficacy data for ENaBL-T, a lentiviral vector for in vivo engineering of BCMA CAR T cells, which supported the first in vivo BCMA CAR-T cell therapy clinical trial for patients with relapse or refractory multiple …
Semen & Cum Pills - Best Volume Pills of 2025 (Supplements for Bigger Loads) - By Semanax
GlobeNewswire
·
April 29, 2025
Limassol, Cyprus, April 29, 2025 (GLOBE NEWSWIRE) -- Particularly in the male enhancement pills industry, Semenax Volume Pills are arguably the best rated and most trusted cum pills for men wanting to increase the volume of their semen, heighten their …
Verona Pharma Reports First Quarter 2025 Financial Results and Provides Corporate Update
GlobeNewswire
·
April 29, 2025
Total net revenue of $76.3 million from Q1 2025 driven by Ohtuvayre® net sales of $71.3 million (+95% vs Q4 2024) ~25,000 prescriptions filled in Q1 2025 Q1 2025 revenue exceeds operating expenses excluding non-cash charges Conference call today at 9:00 a. …
Provectio annonce la nomination du Responsable de son offre Cybersécurité
GlobeNewswire
·
April 29, 2025
Provectio fait évoluer son équipe en annonçant la promotion de Mounir AIT BAHADDA au poste de Responsable de son département Cybersécurité. Positionnée au centre de sa stratégie de croissance, la Cybersécurité pour les TPE et PME bretonnes est une activité …
Unlock Your Trading Edge With Axi at the Finance Magnates Africa Summit
GlobeNewswire
·
April 29, 2025
SYDNEY, April 29, 2025 (GLOBE NEWSWIRE) -- Leading online FX and CFD broker Axi is attending this year’s Finance Magnates Africa Summit (FMAS:25), taking place on May 29-30, 2025, at the Cape Town International Convention Centre in Cape Town, South Africa …
Britisches Unternehmen Stablepharma Ltd. beginnt mit klinischen Studien der Phase I für den weltweit ersten ohne Kühlung auskommenden Tetanus- und Diphtherie-Impfstoff
GlobeNewswire
·
April 29, 2025
LONDON, April 29, 2025 (GLOBE NEWSWIRE) -- Nach der MHRA-Zulassung hat Stablepharma Ltd eine klinische Studie der Phase I mit seinem Hauptkandidaten, dem kühlschrankfreien Tetanus- und Diphtherieimpfstoff SPVX02, begonnen. Die klinische Phase-I-Studie am …